Sandler Capital Management’s DexCom DXCM Stock Holding History

Sandler Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-37,096	Closed	-$3.82M	–	82
2020 Q3	$3.82M	Sell	37,096 -52,464	-59%	-$5.48M	0.38%	63
2020 Q2	$9.08M	Buy	89,560 +33,560	+60%	+$3M	0.86%	45
2020 Q1	$3.77M	Buy	+56,000	New	+$3.48M	0.52%	69
2019 Q2	–	Sell	-147,120	Closed	-$4.38M	–	148
2019 Q1	$4.38M	Buy	+147,120	New	+$5.17M	0.34%	86

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sandler Capital Management's DXCM Position: Q4 2020 in Review

Sandler Capital Management sold out of DexCom (DXCM) in Q4 2020, closing a stake of 37,096 shares — an estimated $3.82M sold.

Sandler Capital Management first reported a position in DXCM in Q1 2019 and held it in 4 quarters. The position peaked at $9.08M in Q2 2020. 734 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Sandler Capital Management reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
Sandler Capital Management sold 37,096 DexCom shares in Q4 2020, an estimated $3.82M.
Sandler Capital Management first reported a position in DexCom in Q1 2019 and held it in 4 quarters.
Sandler Capital Management's DexCom position peaked at $9.08M in Q2 2020.
734 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Sandler Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.